Anterix Inc.

ATEX

CIK 0001304492 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$2M
↑+0.4% +$7Kvs FY2024 (Q4)
Operating Income
$297K
↓-95.8% -$7Mvs FY2024 (Q4)
Gross Profit
$2M
↑+0.4% +$7Kvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Weak
34/100
  • Profitability
    0ROIC -5.8% (10% = solid, 20%+ = moat)
  • Liquidity
    87Current Ratio 2.23 (above 1.5 = solid)
  • Leverage
    0Insufficient data
  • Efficiency
    0Asset Turnover 0.02x (1.0+ = capital-efficient)
  • Growth
    18Revenue YoY +0.4% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin -576.0% · trend +2100.2pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$55K
investment in PP&E
Stock buybacks (TTM)
$3M
share count reduction
Stock-based comp (TTM)
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$417M
everything owned
Total liabilities
$181M
everything owed
Stockholders' equity
$236M
shareholder claim

Recent performance · 52 quarters

Revenue↑+0.4% +$7K
$2M
Net Income↓-185.6% -$14M
$-7M
Free Cash Flow
$-9K
Operating Margin↓-1025.1pts
-576.0%

Drill down